Aslam Fahmida, Khan Faiz Ullah, Yue Yang
International Food and Drug Policy Law and Research Centre, School of Business Administration; Shenyang Pharmaceutical University, China.
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy Xi'an Jiaotong University, Xi'an, China.
Innov Pharm. 2020 Oct 22;11(4). doi: 10.24926/iip.v11i4.1613. eCollection 2020.
Pakistan is one of the countries with the highest number of medications filled per prescription due to overly prescribed antibiotics and injectable drugs. This is due to a lack of ethical practices in prescribing because doctors aresignificantly influenced by lucrative financial incentives of pharmaceutical companies rather than clinical findings. This immoral activity has become significantly amplified over the past few years and continues to be a challenge in Pakistan. Currently, there is no code of ethics for marketing and promotional activities of pharmaceutical companies. This year, authorities have step up and are in the process of creating policies to regulate companies and practitioners. Implementation of these new policies needs vigilance from health officials, strong professional commitment and institutional collaboration. If executed correctly, these polices should create an environment of professionalism within the healthcare sector.
由于抗生素和注射药物的过度处方,巴基斯坦是每张处方配药量最高的国家之一。这是由于处方过程中缺乏道德规范,因为医生受到制药公司丰厚经济激励的显著影响,而非临床研究结果。在过去几年里,这种不道德行为显著加剧,并且在巴基斯坦仍然是一个挑战。目前,没有针对制药公司营销和推广活动的道德准则。今年,当局已加强行动,正在制定监管公司和从业者的政策。这些新政策的实施需要卫生官员保持警惕、坚定的专业承诺和机构间的合作。如果执行得当,这些政策应能在医疗保健部门营造一个专业的环境。